Global BioDiagnostics, Inc. (GBDC) was formed to commercialize the Rapid TB Diagnostic Assay, a technology from the Texas A&M University Health Science Center College of Medicine. This technology would be the world’s first easy-to-use, low-cost tuberculosis diagnostic, which also provides the accuracy of bacteriological culture while being as simple as smear microscopy.